Source: BEFREE ×
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0023440
Disease: Acute Erythroblastic Leukemia
Acute Erythroblastic Leukemia
0.020 Biomarker disease BEFREE Three probes were used for the chromosomal assignment of the human SPI1 oncogene: cDb1 and RaB2 correspond respectively to murine Spi1 and human SPI1 cDNA probes; C45a6B probe is a murine genomic DNA sequence located in the Spi1 5' region and is known as a major SFFV integration site in murine erythroleukemia cells. 2338340 1990
CUI: C2347748
Disease: Adult Erythroleukemia
Adult Erythroleukemia
0.020 Biomarker disease BEFREE Three probes were used for the chromosomal assignment of the human SPI1 oncogene: cDb1 and RaB2 correspond respectively to murine Spi1 and human SPI1 cDNA probes; C45a6B probe is a murine genomic DNA sequence located in the Spi1 5' region and is known as a major SFFV integration site in murine erythroleukemia cells. 2338340 1990
CUI: C4520840
Disease: Erythroleukemia (Erythroid/Myeloid)
Erythroleukemia (Erythroid/Myeloid)
0.020 Biomarker disease BEFREE Three probes were used for the chromosomal assignment of the human SPI1 oncogene: cDb1 and RaB2 correspond respectively to murine Spi1 and human SPI1 cDNA probes; C45a6B probe is a murine genomic DNA sequence located in the Spi1 5' region and is known as a major SFFV integration site in murine erythroleukemia cells. 2338340 1990
CUI: C0023440
Disease: Acute Erythroblastic Leukemia
Acute Erythroblastic Leukemia
0.020 Biomarker disease BEFREE Cellular kinetics of transforming growth factor-beta induced hemoglobin accumulation in the HEL erythroleukemia cell line. 1895755 1991
CUI: C2347748
Disease: Adult Erythroleukemia
Adult Erythroleukemia
0.020 Biomarker disease BEFREE Cellular kinetics of transforming growth factor-beta induced hemoglobin accumulation in the HEL erythroleukemia cell line. 1895755 1991
CUI: C4520840
Disease: Erythroleukemia (Erythroid/Myeloid)
Erythroleukemia (Erythroid/Myeloid)
0.020 Biomarker disease BEFREE Cellular kinetics of transforming growth factor-beta induced hemoglobin accumulation in the HEL erythroleukemia cell line. 1895755 1991
CUI: C0001418
Disease: Adenocarcinoma
Adenocarcinoma
0.040 Biomarker group BEFREE cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. 1388724 1992
CUI: C0018179
Disease: Granular Dystrophy, Corneal
Granular Dystrophy, Corneal
0.200 Biomarker disease BEFREE Assignment of granular corneal dystrophy Groenouw type I (CDGG1) to chromosome 5q. 8044658 1994
CUI: C0027651
Disease: Neoplasms
Neoplasms
0.100 AlteredExpression group BEFREE Transfection of beta IG-H3 expression plasmids into Chinese hamster ovary (CHO) cells led to a marked decrease in the ability of these cells to form tumors in nude mice. 8024701 1994
CUI: C0023418
Disease: leukemia
leukemia
0.020 GeneticVariation disease BEFREE Finally, the beta ig-h3 gene was localized to human chromosome 5q31, a region frequently deleted in preleukemic myelodysplasia and leukemia. 8024701 1994
CUI: C1332977
Disease: Childhood Leukemia
Childhood Leukemia
0.020 GeneticVariation disease BEFREE Finally, the beta ig-h3 gene was localized to human chromosome 5q31, a region frequently deleted in preleukemic myelodysplasia and leukemia. 8024701 1994
CUI: C0026985
Disease: Myelodysplasia
Myelodysplasia
0.010 GeneticVariation disease BEFREE Finally, the beta ig-h3 gene was localized to human chromosome 5q31, a region frequently deleted in preleukemic myelodysplasia and leukemia. 8024701 1994
CUI: C3463824
Disease: MYELODYSPLASTIC SYNDROME
MYELODYSPLASTIC SYNDROME
0.010 GeneticVariation group BEFREE Finally, the beta ig-h3 gene was localized to human chromosome 5q31, a region frequently deleted in preleukemic myelodysplasia and leukemia. 8024701 1994
CUI: C0544848
Disease: Dystrophy, granular
Dystrophy, granular
0.050 AlteredExpression disease BEFREE CDB I is clinically characterized by confluent geographic opacities at the level of Bowman's layer, histopathologically by bandshaped granular Masson-positive subepithelial deposits, and ultrastructurally by the presence of "rod-shaped bodies" and may be a superficial variant of granular dystrophy. 7671605 1995
CUI: C3665346
Disease: Unspecified visual loss
Unspecified visual loss
0.010 Biomarker phenotype BEFREE Visual loss is significantly greater in CDB I, and recurrences after keratoplasty or keratectomy seem to be earlier and more extensive in CDB I. 7671605 1995
CUI: C0010036
Disease: Corneal dystrophy
Corneal dystrophy
0.200 Biomarker disease BEFREE Granular Groenouw type I (CDGG1) and lattice type 1 (CDL1) corneal dystrophies are two distinct potentially blinding conditions. 8875187 1996
CUI: C0016781
Disease: Fuchs Endothelial Dystrophy
Fuchs Endothelial Dystrophy
0.040 AlteredExpression disease BEFREE Expression of beta ig-h3 in sub-epithelial matrix and posterior collagenous layer of Fuchs' dystrophy is consistent with the synthesis of new extracellular matrices by epithelial and endothelial tissues. beta ig-h3 mRNA in corneal epithelium further supports an epithelial source of this protein. 8921218 1996
CUI: C0860659
Disease: Aloof
Aloof
0.010 Biomarker disease BEFREE beta ig-h3-specific fluorescence was found just beneath detached epithelium in the sub-epithelial matrix, abnormal Descemet's membrane and posterior collagenous layer. 8921218 1996
CUI: C1402315
Disease: Vascular lesions
Vascular lesions
0.010 AlteredExpression disease BEFREE Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions. 8624780 1996
Corneal dystrophy, Fuchs' endothelial, 1
0.010 AlteredExpression disease BEFREE Expression of beta ig-h3 in sub-epithelial matrix and posterior collagenous layer of Fuchs' dystrophy is consistent with the synthesis of new extracellular matrices by epithelial and endothelial tissues. beta ig-h3 mRNA in corneal epithelium further supports an epithelial source of this protein. 8921218 1996
CUI: C4699184
Disease: Fuchs
Fuchs
0.010 Biomarker disease BEFREE Beta ig-h3 is synthesized by corneal epithelium and perhaps endotheliumin Fuchs' dystrophic corneas. 8921218 1996
CUI: C0010036
Disease: Corneal dystrophy
Corneal dystrophy
0.200 GeneticVariation disease BEFREE Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. 9054935 1997
CUI: C0036421
Disease: Systemic Scleroderma
Systemic Scleroderma
0.050 AlteredExpression disease BEFREE Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. 9002017 1997
CUI: C0011644
Disease: Scleroderma
Scleroderma
0.020 AlteredExpression disease BEFREE Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. 9002017 1997
CUI: C0339278
Disease: Reis-Bucklers' corneal dystrophy
Reis-Bucklers' corneal dystrophy
0.800 GeneticVariation disease BEFREE This suggests the basic role of this domain in maintaining the proper kerato-epithelin structure which when altered can cause the typical precipitates in the RBCD cornea. 10660331 1998